Mervyn Turner's Insider Trades & SAST Disclosures

Mervyn Turner's most recent trade in SAB Biotherapeutics Inc was a trade of 69,793 Employee Stock Option (right to buy) done . Disclosure was reported to the exchange on Oct. 22, 2021.

Stock Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
SAB Biotherapeutics Inc
Mervyn Turner Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Oct 2021 69,793 69,793 - - Employee Stock Option (right to buy)
SAB Biotherapeutics Inc
Mervyn Turner Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 22 Oct 2021 9,399 9,399 - - Earnout Rights (Restricted Stock Units)
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades